Nabiximols is used for therapy of spasticity linked to MS when other therapies haven't worked, and when an Original trial demonstrates "meaningful enhancement".[four] Trials for FDA approval from the US are underway.The extraction and reporting of knowledge final results was executed at a large stage and didn't contain an in-depth analysis, which h